Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05947695 · ClinicalTrials.gov registry record · NA

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

A NA study of Solid Tumor, Adult and Metastasis, sponsored by Good Samaritan Hospital Medical Center, New York.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05947695: Recruiting NA study of Solid Tumor, Adult and Metastasis, sponsored by Good Samaritan Hospital Medical Center, New York.

NCT05947695 is a NA study of Solid Tumor, Adult and Metastasis that is actively recruiting participants, run by Good Samaritan Hospital Medical Center, New York. The registered enrollment target is 100 participants, below the 189-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05947695, a NA study of Solid Tumor, Adult and Metastasis, is actively recruiting participants, sponsored by Good Samaritan Hospital Medical Center, New York.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of the randomized control trial is to estimate the effect of an oncology clinical nurse specialist-led early intervention multidisciplinary approach to palliative and survivorship care within two previously identified and validated patient groups having metastatic solid tumor malignancy on patient-reported symptom burden, patient-reported overall quality of life (QOL), distress, and overall survival. The primary hypothesis is that the effect of an oncology clinical nurse specialist- led early intervention multidisciplinary palliative and survivorship care model will be significantly higher, as compared to the standard of care approach to palliative and survivorship care, on the primary endpoint of patient-reported symptom burden for patients with metastatic solid tumor malignancy within favorable and very favorable risk groups. Symptom burden includes pain, tiredness, drowsiness, nausea, lack of appetite, depression, anxiety, shortness of breath, and wellbeing.

Primary Outcome

The Edmonton Symptom Assessment System- Revised (ESAS-r) will be used to measure patient reported symptom burden

Interventions

  • BEHAVIORAL Palliative and Survivorship Care Model

Study Locations (1)

New York

  • Good Samaritan University Hospital - West Islip

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-03-02
Est. Completion 2029-03
Phase NA

What NCT05947695 shows while recruiting

NCT05947695 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 189-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (47% lower).

The record links to 2 conditions, with Solid Tumor, Adult appearing as the primary indexed condition, and to 1 intervention - of which Palliative and Survivorship Care Model is the first listed.

NCT05947695 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05947695 about?

NCT05947695 is a clinical study titled "Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer". The purpose of the randomized control trial is to estimate the effect of an oncology clinical nurse specialist-led early intervention multidisciplinary approach to palliative and survivorship care within two previously identified and validated patient groups having metastatic solid tumor malignancy ...

What is the current status of trial NCT05947695?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-03-02. Estimated completion is 2029-03.

What conditions does trial NCT05947695 study?

This clinical trial studies the following conditions: Solid Tumor, Adult, Metastasis.

What interventions are being tested in trial NCT05947695?

The interventions under investigation include: Palliative and Survivorship Care Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT05947695?

This trial is sponsored by Good Samaritan Hospital Medical Center, New York, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05947695 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Solid Tumor, Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05947695's enrollment target sits among peer trials

100 39th of 72 higher than 32 of 72 other Solid Tumor, Adult trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Solid Tumor, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05947695, the US trial registry maintained by the National Library of Medicine. NCT05947695 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.